Clinical Trial Update: A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MK0476 for asthma in children aged 2-5 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0476

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED